Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2002

Amended Announcements
Please refer to the earlier announcement reference number: CR-030225-36299

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

31/12/2002
Quarter4
Financial Year End31/12/2002
The figureshave been audited

Attachments

pharma_klse0212.doc
169 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2002


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/12/2002 
31/12/2001 
31/12/2002 
31/12/2001 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
129,787
139,516
585,237
543,496
2Profit/(loss) before tax
11,287
14,914
61,170
51,604
3Profit/(loss)
after tax and minority
interest
6,779
8,151
37,341
30,804
4Net profit/(loss) for
the period
6,779
8,151
37,341
30,804
5Basic earnings/(loss) per share (sen)
6.80
8.20
37.30
30.80
6Dividend per share (sen)
2.50

8.50
7.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

1.8000
3.2100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced10 Apr 2003  
CategoryFinancial Results
Reference NoCR-030410-44189